ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

15,590Medicare Part D Prescriptions Filled, Including Refills

Rank: 309 out of 6645

$862K Total Retail Price of All Prescriptions

Rank: 431 out of 6645

403 Patients Receiving at Least One Drug in Part D
84%Patients 65 Years and Older
97% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

15% of this provider’s 403 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

6% of this provider’s 14,196 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

36% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $64 among peers.

Prescriptions per Patient

39 is the average number of prescriptions (including refills) per patient, compared to an average of 16.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 864 822 1 2
ATENOLOL 557 508 2 8
ATORVASTATIN CALCIUM 502 492 3 10
OMEPRAZOLE 415 362 4 6
PRAVASTATIN SODIUM 413 380 5 20
LOSARTAN POTASSIUM 370 360 6 12
NEXIUM 324 305 7 40
HYDROCHLOROTHIAZIDE 289 226 8 9
ALENDRONATE SODIUM 285 285 9 14
LIDODERM 276 245 10 53
AMOXICILLIN 275 242 11 107
SIMVASTATIN 267 228 12 1
IBUPROFEN 262 207 13 42
GLYBURIDE-METFORMIN HCL 261 255 R 14 95
METOPROLOL SUCCINATE 251 235 15 24
TRAMADOL HCL 240 219 16 30
TRIAMCINOLONE ACETONIDE 240 209 16 55
TAMSULOSIN HCL 231 230 18 22
METFORMIN HCL 227 202 19 7
RANITIDINE HCL 223 197 20 51
AMLODIPINE BESYLATE-BENAZEPRIL 223 203 20 97
BENAZEPRIL HCL 218 211 22 21
CRESTOR 214 199 23 34
NAPHAZOLINE HCL 211 195 24 215
LOVAZA 202 195 25 68
AMPICILLIN TRIHYDRATE 187 158 26 327
PATANOL 187 170 26 131
DIOVAN 185 179 28 19
ZOLPIDEM TARTRATE 168 141 29 17
ACTONEL 166 164 30 92
FLUOCINONIDE 165 136 31 130
ACTOS 161 152 32 71
FLUTICASONE PROPIONATE 160 147 33 26
GABAPENTIN 159 141 34 18
DIPHENOXYLATE-ATROPINE 157 124 35 214
ACETAMINOPHEN-CODEINE 143 131 S3 36 80
GLYBURIDE 141 129 R 37 58
PROAIR HFA 136 121 38 32
CREON 130 109 39 114
CELEBREX 128 117 40 54
PROPRANOLOL HCL 127 95 41 151
PROMETHAZINE VC 126 109 R 10 42 444
LIPITOR 119 119 43 69
ISOSORBIDE MONONITRATE ER 115 106 44 66
ALBUTEROL SULFATE 113 93 45 112
LEVOTHYROXINE SODIUM 111 83 46 4
LANSOPRAZOLE 107 107 47 163
TRIAMTERENE-HCTZ 105 105 48 52
HYDROXYZINE HCL 101 96 R 49 161
SINGULAIR 101 99 49 76
DIOVAN HCT 95 87 51 64
CARVEDILOL 89 77 52 25
MELOXICAM 85 84 53 46
DICLOFENAC SODIUM 83 82 54 109
PLAVIX 83 74 54 49
HYDROCODONE-ACETAMINOPHEN 79 46 S3 56 5
HYDROCORTISONE 77 76 57 229
NIFEDIPINE ER 76 76 58 82
NAPROXEN 72 70 59 88
FAMOTIDINE 70 64 60 33
FINASTERIDE 70 70 60 73
GUANFACINE HCL 65 65 R 62 429
VOLTAREN 63 63 63 108
AZITHROMYCIN 60 44 64 44
CLOPIDOGREL 58 58 65 36
PIOGLITAZONE HCL 54 46 R 66 184
CLOBETASOL PROPIONATE 52 43 67 228
COLCRYS 51 51 68 192
QVAR 50 46 69 103
PANTOPRAZOLE SODIUM 50 46 69 29
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.